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Abstract — This work aims to classify the DNA sequences of 
healthy and malignant cancer respectively. For this, supervised 
and unsupervised classification methods from a functional context 
are used; i.e. each strand of DNA is an observation. The 
observations are discretized, for that reason different ways to 
represent these observations with functions are evaluated. In 
addition, an exploratory study is done: estimating the mean and 
variance of each functional type of cancer. For the unsupervised 
classification method, hierarchical clustering with different 
measures of functional distance is used. On the other hand, for the 
supervised classification method, a functional generalized linear 
model is used. For this model the first and second derivatives are 
used which are included as discriminating variables. It has been 
verified that one of the advantages of working in the functional 
context is to obtain a model to correctly classify cancers by 100%. 
For the implementation of the methods it has been used the fda.usc 
R package that includes all the techniques of functional data 
analysis used in this work. In addition, some that have been 
developed in recent decades. For more details of these techniques 
can be consulted Ramsay, J. O. and Silverman (2005) and Ferraty 
et al.  (2006). 
 
Index Terms— Depth of functional data, DNA, functional data 
analysis, functional distances, statistical classification 
I. INTRODUCTION 
 
HE DNA Microarray chips and high-density 
oligonucleotide are widely used in modern biomedical 
research and can serve as a guide for the diagnosis and 
treatment of some diseases.  
 
   One of the most interesting and current applications is the 
characterization and classification of different types of cancer 
Singh D. et al. (2002). Microarray data show expression levels 
of many genes with respect to a number of observations 
(samples) and therefore can be considered as functional data or 
data with high dimension. 
 
   To this effect, it is very common to use multivariate methods 
to classify or create groups, for example according to Romualdi 
et al., (2003); Wessels et al., (2005); Tárraga et al. (2008) the 
best methods are: the K nearest neighbor method (KNN) and 
Diagonal Linear Discriminant Analysis (DLDA). Also, in the 
work of Dudoit et al. (2002) you can see a comparison of 
discrimination methods for the classification of tumors using 
gene expression data.  
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   However, these methods of classical statistics do not perform 
well when the dimension of the data is very high relative to the 
size of the sample. (López-Pintado et al., 2010) 
 
   In this paper, a new approach is proposed for the classification 
of different types of cancer using models of Functional Data 
Analysis (FDA). This recent field of statistics allows processing 
data with high dimension and take advantage of their functional 
character. 
 
   Specifically, it is used a generalized functional linear model 
fit to classify the levels of expression of a set of genes in a type 
of tumor that affects a group of individuals.  
 
   To illustrate procedures of Functional Analysis of data is 
used, the database "prostate” belonging to the package " 
depthTools " R, which contains a random sample of 25 non-
tumor samples (healthy) and 25 tumor samples (malignant), in 
which have been measured  the expression levels of 100 genes. 
For more details on the data, you can consult Singh D. et al. 
(2002). 
 





AIC Akaike Information Criteria 
DNA Deoxyribonucleic Acid 
DLDA Diagonal Linear Discriminant Analysis 
FDA Functional Data Analysis 
FPLS Functional Partial Least Squared - Principal Component 
FM depth Fraiman and Muniz depth 
GCV Generalized Cross-Validation 
GFLM Generalized Functional Linear Model 
KNN K nearest neighbors estimator 
LLR Local Linear Smoothing 
NW Nadaraya Watson Kernel Estimator 
PL Partial Least - Principal Component 
RP depth Random Projection depth 
   Finally, to implement the FDA procedures, the R statistical 
software is used, because the R package fda.usc has applicable 
routines for functional data. This package carries out 
exploratory and descriptive analysis of functional data, 
analyzing its most important features such as depth 
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measurements or functional outliers detection, among others. 
Besides, fda.usc includes the functions implemented by Ferraty 
et al.  (2006). 
II. FUNCTIONAL DEFINITION AND REPRESENTATION 
 
    X is defined as functional variable of interest, level of 
expression of genes taking values in a normed space (or semi - 
normed) F, and the set {x1, x2,…,xn} is considered the 
functional data to be analyzed which come from 𝑛 functional 
variables X1, X2,…,Xn identically distributed as X. Functional 
data are discretized in a set of points {𝑡𝑗}𝑗=1
𝑑  not necessarily 
equidistant (as here). 
 
   Therefore, it has 𝑑 (genes) assessments for each of the 𝑛 
(observations) functional variables, that is, with a matrix of 50 
rows representing discretized curves and 100 columns 
representing points to evaluate. The first 25 rows correspond to 
levels of expression of normal tumors and the following 25 
rows to malignant tumors. 
 
   In Figure 1, you can see in black the different levels of the 
genes for normal tumors and red for malignant. At first glance 
this figure does not distinguish differences between tumor 
types. 
 
   To appreciate a greater difference on the relationship of genes 
and their expression level, for each tumor type a panel of six 
graphs is presented in Figure 2, in each row there are three 
graphs corresponding to normal tumors, first row, and 
malignant tumors, second row. The graphs in each row 
corresponds respectively to functional data (first), first 
derivative (second), and second derivative (third). 
 
   The representation made in Figure 1 for the functional data 
implicitly assumes a space 𝐿2 which does not allow adequate 
discrimination between tumor types; you can see that by 
studying the behavior of the level of gene expression in other 
spaces (see Figure 2) can have a better discrimination. 
Specifically, the functional space of the second derivative of the 
functional data provides greater features (depth and variability) 
to discriminate between the two tumors. 
 
 
Figure 1: Graph of functional data represented by curves of black color for 
normal and red for malignant tumors. 
 
 
Figure 2: Panel of six graphs, in each row there are three graphs corresponding 
to the functional data, first derivative and second derivative; in the first row for 
normal tumors and in the second row for malignant tumors. 
 
   The representations in bases made for the first curve of the 
sample’s functional data are shown in Figure 3: B-Splines (5, 
20), Kernel Smoothing (KNN, LLR, NW) and Principal 
Components (PL and FPLS). These representations allow you 
to work the problem in finite dimension. 
 
   For the selection of a base, a setting parameter must be 
calibrated that allows a better representation; for this selection 
has been considered as criterion the Generalized Cross-
validation (GCV) method. For more information about base 
types, methods and validation criteria, see Febrero-Bande, M. 
and Oviedo de la Fuente, M. (2012). 
 
   For the classification of tumors we work with representations 
in base; but for calculating distances and exploratory analysis 
of functional data we do not work with representation in base. 
The fda.usc R package is used to perform calculations using the 
corresponding numerical approximations. 
 
   As can be seen in Figure 3, depending on the method and the 
adjustment parameter representations in base, they are different. 
In the case of a representation by principal components we can 
see that there is not much difference between the PL and PLS 
method. 
 
      In Table II the following indicators are shown: the 
percentage of variance explained for each component; the 
correlation between the level of gene expression; and the type 
of tumor. These indicators are calculated for the original data, 
its first derivative and second derivative. 
 
 
Figure 3: The base representations made to the first observation of the 
functional data with bases: B -Splines (5.20), Kernel Smoothing (KNN, LLR, 
NW) and Principal Components (PL and FPLS). 
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   TABLE II 
PERCENTAGE OF EXPLAINED VARIANCE FOR EACH COMPONENT 
AND THE CORRELATION BETWEEN THE EXPRESSION LEVEL OF 
GENES AND TUMOR TYPE FOR THE ORIGINAL DATA, ITS FIRST 
DERIVATIVE AND SECOND DERIVATIVE 





75.21 17.8 6.98 
Tumor type 
correlation 




79.75 14.78 5.47 
Tumor type 
correlation 






71.85 23.76 4.39 
Tumor type 
correlation 




75.3 18.64 6.06 
Tumor type 
correlation 






68.8 22.22 5.96 
Tumor type 
correlation 




74.27 19.85 5.88 
Tumor type 
correlation 
73.7 42.6 52.2 
 
   About 70 % of the total variability of the data is explained by 
the first component, regardless of the method of principal 
components to be used; the variability explained by the second 
component increases to about 20 % when working in the spaces 
of the functions of the first and second derivatives. 
 
   In general, we can say that the first two components explain 
about 90 % of the variability; the first component has a strong 
positive ratio of about 70 % in all methods; and the second 
component has a negative ratio using the method PL and a 
positive  one using the PLS method. 
III.  DISTANCE BETWEEN FUNCTIONAL DATA 
    
   In this section it has been applied a metric for the 𝐿2 space 
and 4 semi - metrics for other semi - normed spaces, in order to 
calculate the distance between the functional data (for more 
information on the definition of each measure, see Febrero-
Bande, M. and Oviedo de la Fuente, M. (2012). For calculating 
these measures, have been implemented the following functions 
developed in the fda.usc package: 
 
1) metric.lp (for functional data represented in a 𝐿𝑝 space, 
with p = 2). 
2) semimetric.deriv (for functional data in the space of 
functions of the first and second derivative). 
3) metric.pl (based on the method of principal components 
(PL), it calculates a PL semi- metric between functional 
data). 
4) metric.mplsr (based on the principal component method 






 PERCENTAGE OF CORRECT CLASSIFICATION OF TUMORS FOR 
EACH METHOD. 
Function Space % success 
metric.deriv First derivative 40 
metric.deriv Second derivative 78 
metric.pca Principal Component PL 84 
metric.mplsr Principal Component FLPS 98 
metric.lp L2 40 
 
   The result of each of these functions (metric and semi- metric) 
is a matrix of dimension 50 x 50 containing the distances 
between all curves (functional data). 
 
   You can use this information as a classification rule, since it 
is expected that the closest curves belong to the same tumor. 
In Figure 4 the dendrogram for the semi - metric Principal 
Component FPLS is shown.  
 
   The results presented in Table III, are the percentages of 
correct classification and correspond to distance functions (the 
metric and semi- metric). The highest values are those 
calculated by the metric.lp and metric.deriv functions. With the 
semi - metric calculated by the metric.mplsr function it was 
achieved a 98 % of success; it should be mentioned that only 
came to classify erroneously one case (curve 40: a malignant 
cancer classified as normal). Cuevas et al., (2001) use an 
approach based on density estimation for doing a Cluster 
Analysis. 
 
   Clearly, with these results is more advisable to work in semi 
- normed spaces to identify differences between the expressions 
of genes according to cancer types for better classification. 
IV. EXPLORATORY ANALYSIS OF FUNCTIONAL DATA 
 
For this section, the exploratory data analysis has been divided 
in two parts: 
 
1) Variability and central tendency estimation 
2) Outliers detection 
 
   Estimates of central tendency and variability for each type of 
cancer are done using robust methods, therefore there is not a 
great influence by outliers for estimates. 
 
   However, it was decided to conduct a study of outliers 
detection to illustrate the methodology to be used in the case of 
not having these robust methods. 
 
 
Figure 4: Dendrogram for the semi - metric Principal Component FPLS (98% 
correct classification) 
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Figure 5: Functional Mean for original data and second derivative for each 
type of tumor. 
 
A. Variability and central tendency estimation  
 
   The descriptive exploratory analysis consists in: calculating 
the mean, and functional variance of the expression levels of 
genes and its second derivative. This study is performed for 
each type of tumor to differentiate central tendency and 
variability of functional data. 
 
   In Figure 5, we can appreciate the functional mean for the 
original data and its second derivative. In each graph the 
functional mean is distinguished for each type of cancer.  
 
   As shown in the graph on the left, the difference between the 
curves of the functional means for the original data is not very 
noticeable; on the other hand, in the right picture for functional 
mean of the second derivative you can see a greater difference. 
 
   Overall the two graphs give us an idea that the expression 
levels of genes tend to values between -0.5 and 1.5, 
approximately; whereas, the second derivative between -0.5 
and 0.5. In addition, we can see that there is greater variability 
in the trend of the original data than in the second derivative. 
 
   In Figure 6, it is shown a graphical representation of the 
confidence ball representing the estimation limits, where the 
functional mean oscillates for each type of functional data in 
each space. It has been applied the smoothing bootstrapped 




Figure 6: Confidence balls for Functional Mean for original data and second 
derivative for each type of tumor. 
 
Figure 7: Functional variance for the original data and second derivative for 
each type of tumor 
 
   In Figure 6, light blue curves are the representation of 
confidence balls at a level of 95% generated by the bootstrap 
method for functional mean (black color curve). For graphics 
on the left, gray curves correspond to the original data and for 
graphs on the right, they are the second derivative's. 
 
   In Figure 7 the curves of variance for each type of cancer are 
shown in the spaces of the original data (graph on the left) and 
the second derivative’s (right graph). Here you can see a 
marked difference between the variance of normal and 
malignant tumors. In malignant tumors a greater range of 
variation is observed that in normal ones; this same behavior is 
similar in the two spaces of functional data. 
 
B. Outliers Detection 
 
   Subsequently, a study on the presence of outliers is done 
because they could affect the estimation and performance 
(classification) of the model. The depth is a measure whose 
concept has emerged in the literature of robustness, measures 
how deep (or central) is a benchmark for a population (or 
sample). Therefore, those points having large depth values, will 
be closer to the behavior of the central data; and if they have 
less deep values, they will be potential candidates for outliers. 
For more information about the definition of a function of depth 
see Zuo Y. and Serfling R. (2000). 
 
   In univariate data, the median would be the deepest point of 
the set of points. For this study, we have applied the following 
depth measures which are included in the package fda.usc: 
Mode (mode depth); Median defined by Fraiman (Fraiman and 
Muniz, 2001) (FM depth); and Random Projections (RP depth).  
 
   Having studied the central tendency and variability of the data 
we continue with the detection of outliers in the sample. We 
start with an analysis with all the original data by calculating 
three measures of depth (shortened by 10 %) and the difference 
of each with respect to the median of functional data is observed 
(see Figure 8); subsequently, a scatter plot is made between the 
different depth measurements to see if there are outliers (the 
points with smaller depth values and that are not aligned to the 
general behavior of the points are considered outliers). 
 
   The analysis for the detection of outliers is accounted 
considering all the sample data; but this analysis is applicable 
for each subsample defined by the type of tumor. Table IV 
summarizes the curves (or outliers) considering the total sample 
and the subsample for each type of cancer. 
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Figure 8: A panel of six graphs, the first row has the representation of depth 
measurements contrasted with the median of the total sample. The second row 
shows the scatter plots between all the depth measurements. 
 
   In the code attached to this work can be found the procedure 
developed for the calculation of depth measurements as their 
graphic representation for the entire sample and for each 
subsample.  
    
   In Figure 8, a panel of six charts that are distributed as follows 
is presented: in the first row is the representation of depth 
measurements contrasted with the median of the total sample; 
and in the second row, we have the scatter plots between all the 
depth measurements; it should be noted that have been marked 
with a red box the outliers for each graph and the order 
considered for reading the graphs is from left to right. 
 
   Contrasting depth measurements (second row of the graphics 
panel of Figure 8), clearly can be observed outliers in all three 
cases. In the first graph two points are identified as atypical 
functional data representing curves 2 and 21 belonging to the 
normal tumor sample; the same curves also are identified as 
atypical curves by observing the third graph; while in the 
middle graph three atypical points are observed, curves 2, 21 
and 3.  
 
   To confirm this visual analysis, an analytical rule is applied 
which  considers as atypical functional data the curves  whose 
depth values are less than a quantile defined based on all 
calculated values of depth of each sample’s data (curves).  
 
   In the case of the mode depth measurements to a 1% quantile, 
it could be identified as atypical data curves 2 and 21; this also 
happens with the depth measurement of random projections, 
i.e., the curves 2 and 21 are identified as atypical again with 1% 
quantile. Whereas, for the identification of atypical data in 
FM’s median it is considered a 5% quantile and the curves are 
identified as 2 and 3.  
 
   Table IV summarizes functional data identified as atypical, 
considering each depth measurement and each sample. 
 
TABLE IV 









Mode 2.2 2.2 40 
FM 2.3 2.3 40 
Rp 2.2 2.2 40.5 
    
 
Figure 9: Curves identified as atypical functional data for each type of depth 
measurement. 
 
   In Figure 9, three graphs are shown. On each one, original 
curves are presented in gray and data identified as atypical in 
blue and red. 
 
   These results at first glance might indicate to us that there are 
only atypical data in normal tumors and that there are no 
atypical in malignant tumors, but performing the same analysis 
to identify atypical data in the sample of malignant tumors, it 
comes down to detect as atypical curves 40 and 48. 
 
   While in the subsample of malignant tumors curves 40 and 41 
are identified as outlier. It is recalled that in the " Distance 
between functional data " section, in applying the distance by 
principal components to make a first approach to a 
classification rule, could not be correctly classify the curve 40. 
V.   GENERALIZED FUNCTIONAL LINEAR MODEL (GFLM) 
   This section provides a Generalized Linear Functional Model 
(GFLM) where the functional covariates are: the level of 
expression of genes denoted as: X=X (t), and, the first X'(t) and 
its second derivative X''(t) denoted as X1 and X2, respectively; 
and as response scalar variable (binary) the cancer type denoted 
as Y (0 = normal tumor, 1 = malignant tumor).  
 
In this case, as the GFLM works with a binary response 
variable, this model provides a classification rule for the type of 
cancer (Bayes’ rule). 
 
   This model is also called Functional Logistic Regression 
(Febrero-Bande, M. and Gonzalez-Manteiga, W. 2012), i.e. the 
models explain the relationship between Y (binary response) 
and a functional covariate X (t) by base representation X (t) and 
β (t). The functional model of logistic regression of the 
probability πi, the occurrence of an event, Yi = 1, rather than Yi 
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TABLE V 
 PERCENTAGE OF CORRECT CLASSIFICATION OF TUMORS 
Number Model AIC 
% 
classification 
1 Y~X 49.7 82 
2 Y~X1 21.8 96 
3 Y~X2 24.1 96 
4 Y~X+X1 22.0 100 
5 Y~X+X2 22.0 100 
6 Y~X1+X2 22.0 100 
7 Y~X+X1+X2 32.0 100 
 
   Where πi is the expectation of Y given Xi (t) modeled as 
follows:
 
With 𝝐i as independent errors with mean zero. 
 
   The functional variables used to estimate the model are: 
 
1) Y = binary variable that identifies the type of tumor (0 = 
normal tumor, 1 = malignant tumor) 
2) X = expression level of 100 genes of each individual 
3) X1 = first derivative of the expression level of 100 genes 
of each individual 
4) X2 = second derivative of the expression level of 100 genes 
of each individual 
 
   From these variables, they were estimated and compared 
seven models, Table III summarizes the characteristics 
evaluated to select the best model to use for the classification of 
tumor types. It is worth mentioning that the "fregre.glm" 
function from the R fda.usc package  was used and B - Spline 
as representation basis for the seven models. 
 
   Additionally, it was explored with a representation based on 
principal component (PLS) for models 1 and 2 (it was used  an   
R code for this) to improve results in adjustment and 
classification; but the results are similar to the representation in 
B - SPLINE therefore not proceeded to make estimates with this 
type of representation based . 
 
   The criteria used are: AIC (while lower is better); the 
percentage of tumors that are classified correctly from the total 
sample (% classification); and the percentage of prediction, that 
is, the percentage of tumors that are classified correctly from 
the total test sample (% Prediction). To calculate the prediction 
percentage, 10 test samples were used, 5 of normal tumors and 
5 of malignant tumors; these were taken randomly setting a 
seed. 
 
   In the first model (see Table V), only are considered the 
original data (levels of gene expression), this is the model that 
explain less (AIC = 49.7) and its classification and prediction 
percentages are 82 % and 80 % respectively; on the other hand, 
with respect to the significance of the model parameters, we 
have that the first component (ab.bspl4.1) is significant 
(0.00639) to a level of significance of 5%. All parameters for 
the other models are not statistically significant at a level of 
significance lower than 1 %. 
 
   The second model (see Table V), has the lowest AIC (21.8) 
of all the proposed models, but there are models with better 
percentages of classification and prediction. From Model 4 to 
Model 7, the percentage of classification and prediction is 100 
%, except for model 6 which has only a 70 % of prediction. 
 
   In general, when only are considered single-variable models 
of explanation for the type of cancer; AIC coefficient, the 
percentage of classification and prediction are the worst of all 
the proposed models. 
 
   Furthermore, it can be seen in Table V that increasing the 
number of variables in a model, the classification percentage 
improves up to 100%; however, when only considered in model 
6, the functional variables: first and second derivative, the 
percentage of prediction is 70 %; and, when you have a more 
complex model with three functional variables considering the 
original data, its first and second derivative prediction, the 
model improves prediction but worsens explanation (best fit); 
In conclusion, one has that the complex model is good for 
predicting but not to explain the behavior of the cancer type 
variable. 
 
   In Table V, the painted yellow rows indicate the two models 
that have the same characteristics of explanation (best fit), 
classification and prediction; models 4 and 5 are the best 
models of seven models estimated. Therefore, the best model to 
classify tumors in normal and malignant is that which consider 
original data and one additional functional variable which can 
be the first or second derivative of the original data; this model 
comes to have a classification and prediction efficiency of 
100%. 
 
   If the classification results obtained with models 4 and 5 are 
compared with the classification procedure by means of the 
distances between functional data used in section three which 
showed an efficiency of 98 %, we could say that for this sample, 
a Functional Generalized Linear Model is (GFLM) is more 
robust to the presence of outliers, as it allows an classification 
and prediction efficiency of 100%. 
 
   Finally, to complete this work Figure 10 shows the 
adjustments of the GLFM models for the cancer type variable 
when the entire sample of tumors is considered. It is worth 
mentioning that the graph settings for models of more than one 
explanatory functional variable is equal for all, because from 
model 4 to model 7 all have a classification percentage of 100%. 
 
Figure 10: Functional Mean for original data and second derivative for each 
type of tumor. 
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VI. CONCLUSIONS AND FUTURE RESEARCH 
 
1) It has greater discrimination when working with the first 
and second derivative of the expression of genes. This is 
reflected also in calculating the functional mean and 
variance in these spaces. 
 
2) In the section "Outliers Detection", curves 2,3,21 and 40 
are determined as outliers. These are not classified 
correctly using the cluster method but by using the 
functional generalized linear model. 
 
3) Increasing the number of variables in the functional 
generalized linear model, the classification percentage 
improves up to 100%. The functional variables included 
were the first and second derivative. 
 
4) The functional data analysis is very recent in the fields of 
statistics and medicine, despite this there is an increased 
interest in using this methodology. It is intended to 
continue to address problems of classification in other 
areas of science. 
 
5) Specifically for the medical field, will work to make a 
functional generalized additive linear model that eliminates 
the restriction of linearity for the independent variables. 
 
6) Besides, it is addressing functional models to describe the 
relationship of the expressions of genes with other 
variables related to cancer. 
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